- Home
- MOGU vs LIXT Comparison
MOGU vs LIXT Comparison
Compare MOGU & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- LIXT
- Stock Information
- Founded
- MOGU 2011
- LIXT 2005
- Country
- MOGU China
- LIXT United States
- Employees
- MOGU N/A
- LIXT N/A
- Industry
- MOGU Business Services
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- LIXT Health Care
- Exchange
- MOGU Nasdaq
- LIXT Nasdaq
- Market Cap
- MOGU 19.8M
- LIXT 20.5M
- IPO Year
- MOGU 2018
- LIXT N/A
- Fundamental
- Price
- MOGU $2.55
- LIXT $4.19
- Analyst Decision
- MOGU
- LIXT
- Analyst Count
- MOGU 0
- LIXT 0
- Target Price
- MOGU N/A
- LIXT N/A
- AVG Volume (30 Days)
- MOGU 8.8K
- LIXT 89.5K
- Earning Date
- MOGU 11-21-2025
- LIXT 11-12-2025
- Dividend Yield
- MOGU N/A
- LIXT N/A
- EPS Growth
- MOGU N/A
- LIXT N/A
- EPS
- MOGU N/A
- LIXT N/A
- Revenue
- MOGU $19,462,964.00
- LIXT N/A
- Revenue This Year
- MOGU N/A
- LIXT N/A
- Revenue Next Year
- MOGU N/A
- LIXT N/A
- P/E Ratio
- MOGU N/A
- LIXT N/A
- Revenue Growth
- MOGU N/A
- LIXT N/A
- 52 Week Low
- MOGU $1.83
- LIXT $0.64
- 52 Week High
- MOGU $8.10
- LIXT $6.26
- Technical
- Relative Strength Index (RSI)
- MOGU 43.62
- LIXT 46.67
- Support Level
- MOGU $2.54
- LIXT $3.53
- Resistance Level
- MOGU $2.65
- LIXT $4.76
- Average True Range (ATR)
- MOGU 0.14
- LIXT 0.41
- MACD
- MOGU 0.01
- LIXT 0.00
- Stochastic Oscillator
- MOGU 27.27
- LIXT 48.26
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.